a Department of Microbiology , Apollo Cancer Institute , Chennai , India.
b Department of Histopathology , Apollo Cancer Institute , Chennai , India.
Infect Dis (Lond). 2017 Jul;49(7):528-531. doi: 10.1080/23744235.2017.1296184. Epub 2017 Mar 6.
Corynebacterium species other than Corynebacterium diphtheriae were mostly considered contaminants in the past, but there are reports of their association with wide variety of human infections lately. In this study, we look into Corynebacterium species isolated from breast abscess patients and assess their antimicrobial susceptibility pattern and treatment outcomes.
Pus samples from suspected breast abscess cases were examined from October 2014 to September 2015. Growth of Gram-positive bacilli morphologically resembling Corynebacterium species were identified by matrix-assisted laser desorption/ionization- time of flight mass spectrometry identifications generated by the Vitek MS system (bioMérieux, France) (MALDI-TOF Vitek MS system) and antimicrobial susceptibility was done.
Corynebacterium species were isolated from 10 female breast abscess patients with median age of 36 years (range 25-59 years). Out of the 10 isolates four isolates were identified as C. kroppenstedtii; one isolate as C. striatum and five isolates were identified as C. amycolatum/C.xerosis. Out of four isolates of C .kroppenstedtii, two isolates were resistant to cotrimoxazole and one C. striatum isolate was resistant to penicillin, ampicillin, cotrimoxazole and clindamycin. Of the five isolates identified as C amycolatum/C xerosis, all were sensitive to vancomycin and linezolid but resistant to clindamycin. All the patients were treated with incision, drainage and antibiotics based on the sensitivity pattern; eight were cured and two patients did not come for follow-up.
Corynebacterium species should be considered one of the causative agents of breast abscess and a varied susceptibility profile amongst the different species makes susceptibility testing important. Identification by MALDI-TOF Vitek MS system may not differentiate between C. amycolatum and C. xerosis.
过去,除白喉棒状杆菌外的棒状杆菌属细菌大多被认为是污染物,但最近有报道称它们与多种人类感染有关。在这项研究中,我们研究了从乳腺脓肿患者中分离出的棒状杆菌属细菌,并评估了它们的抗菌药物敏感性模式和治疗结果。
从 2014 年 10 月至 2015 年 9 月,检查了疑似乳腺脓肿病例的脓液样本。通过 Vitek MS 系统(法国生物梅里埃公司)(基质辅助激光解吸/电离-飞行时间质谱仪系统,MALDI-TOF Vitek MS 系统)生成的微生物鉴定方法鉴定出形态上类似于棒状杆菌属的革兰氏阳性杆菌,并进行了抗菌药物敏感性检测。
从 10 名女性乳腺脓肿患者中分离出棒状杆菌属细菌,中位年龄为 36 岁(25-59 岁)。10 株分离株中,4 株鉴定为克氏棒状杆菌,1 株鉴定为纹带棒状杆菌,5 株鉴定为糖多孢菌/类干燥棒状杆菌。4 株克氏棒状杆菌中有 2 株对复方磺胺甲噁唑耐药,1 株纹带棒状杆菌对青霉素、氨苄西林、复方磺胺甲噁唑和克林霉素耐药。5 株鉴定为糖多孢菌/类干燥棒状杆菌的分离株均对万古霉素和利奈唑胺敏感,但对克林霉素耐药。所有患者均根据药敏结果采用切开引流和抗生素治疗,8 例治愈,2 例未随访。
棒状杆菌属细菌应被视为乳腺脓肿的一种病原体,不同种之间的药敏谱差异较大,因此药敏试验很重要。基质辅助激光解吸/电离-飞行时间质谱仪系统的鉴定可能无法区分糖多孢菌和类干燥棒状杆菌。